Innovest Global, Inc. has secured a strategic partnership with the Southern California Biomedical Counsel. This action follows the announcement of company's Biotech Division’s advisory board, and is a catalyst for the division’s 2019 business plan. Innovest’s biotechnology division expects a variety of developments, from both StemVax and its new efforts. Innovest is enthusiastically closing out a year which was marked by a series of developments and revenue acquistions, which effectivelty set a platform that can scale significantly in 2019 and beyond.